South Korea's diagnostics imports fall
This article was originally published in Clinica
Imports of in vitro diagnostics into South Korea fell 1% in 1997 after several years of double-digit growth, reflecting the country's economic woes. Imports totalled $73.3 million and accounted for a slightly larger share - at 6.7% - of the South Korean pharmaceutical market than in 1996, reports Pharma Koreana.
You may also be interested in...
Arcadia prohibited from arguing against Advantice’s appeal of National Advertising Division decision that Kerasal Fungal Nail Renewal ad claims weren’t supported. Arcadia violated confidentiality rule by publicizing NAD decision before the review was officially closed.
The C-suite leaders schemed to falsely record shipments of unwanted products to distributors as sales so the company could meet revenue projections, the government charged.
Gallium has been approved as a diagnostic agent by the US agency to help early detection of prostate cancer spread in patients who qualify for treatment with surgery or radiation therapy.